☆ 4.7 Meeting Abstract

MORE THAN HALF OF RA PATIENTS WITH A LIFETIME HISTORY OF MOOD DISORDERS WERE ANXIOUS AND DEPRESSED DURING THE COVID-19 PANDEMIC: RESULTS FROM THE CANADIAN EARLY COHORT (CATCH) STUDY

ANNALS OF THE RHEUMATIC DISEASES (2022)

Journal

ANNALS OF THE RHEUMATIC DISEASES

Volume 81, Issue -, Pages 204-204

Publisher

BMJ PUBLISHING GROUP

DOI: 10.1136/annrheumdis-2022-eular.2411

Keywords

Funding

Amgen
Pfizer Canada
AbbVie Corporation
Medexus
Sandoz Canada
Fresenius Kabi Canada
Organon Canada
Janssen Canada
UCB Canada
Bristol-Myers Squibb Canada
Hoffman La Roche Limited
Sanofi Genzyme
Eli Lilly Canada
Merck Canada
Gilead Sciences Canada

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

MORE THAN HALF OF RA PATIENTS WITH A LIFETIME HISTORY OF MOOD DISORDERS WERE ANXIOUS AND DEPRESSED DURING THE COVID-19 PANDEMIC: RESULTS FROM THE CANADIAN EARLY COHORT (CATCH) STUDY

Journal

ANNALS OF THE RHEUMATIC DISEASES

Publisher

BMJ PUBLISHING GROUP

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

MORE THAN HALF OF RA PATIENTS WITH A LIFETIME HISTORY OF MOOD DISORDERS WERE ANXIOUS AND DEPRESSED DURING THE COVID-19 PANDEMIC: RESULTS FROM THE CANADIAN EARLY COHORT (CATCH) STUDY

Journal

ANNALS OF THE RHEUMATIC DISEASES

Publisher

BMJ PUBLISHING GROUP

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper